Exhibit 16.1
McGladrey LLP
80 City Square Boston, MA 02129 O 617.912.9000 F 617.912.9001 www.mcgladrey.com |
April 17, 2014
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read Karyopharm Therapeutics Inc.’s statements included under Item 4.01 of its Form 8-K filed on April 17, 2014 and we agree with such statements concerning our firm.
Sincerely,
/s/ McGladrey LLP